Ignite Creation Date:
2025-12-24 @ 10:55 PM
Ignite Modification Date:
2025-12-25 @ 8:23 PM
Study NCT ID:
NCT03433469
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-01-31
First Post:
2018-01-25
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery
Sponsor:
University of California, San Francisco
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-31
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-10-31
Completion Date Type:
ESTIMATED
First Submit Date:
2018-01-25
First Submit QC Date:
None
Study First Post Date:
2018-02-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-12-20
Results First Submit QC Date:
None
Results First Post Date:
2024-01-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-29
Last Update Post Date:
2025-01-31
Last Update Post Date Type:
ACTUAL